Jun 16, 2026 · 6 min
SpaceX surges post-IPO as Netflix drops after losing Roku bid
SpaceX Rallies Third Straight Day, Netflix Falls, Moderna Rises
This episode tracks the massive market disruptions caused by SpaceX's historic IPO, a major realignment in the streaming wars, and regulatory momentum for biotech.
- 1SpaceX shares rallied for a third straight day following its record IPO, putting the aerospace giant on track to rival Amazon in value.
- 2Netflix stock dipped after losing a major bidding war for Roku to Fox Corporation, shaking up the streaming distribution market.
- 3Moderna shares surged ahead of an FDA advisory committee meeting on the back of favorable briefing documents for its flu vaccine.
The brief
SpaceX is rewriting the rules of the aerospace sector following a record-breaking initial public offering, sending its stock soaring for three consecutive days and putting the company on track to challenge Amazon in total valuation.
The streaming landscape is shifting rapidly as Netflix suffers a stock dip after losing a high-stakes bidding war for Roku to Fox Corporation, signaling a major consolidation of distribution power in the entertainment market.
Moderna is experiencing its own market surge, driven by favorable Food and Drug Administration briefing documents ahead of an advisory committee meeting regarding its new influenza vaccine.
What was said on this episode
6 statements · 5 positive · 1 negative
SpaceX stock is on track to surpass Amazon in market value.
“the gains are putting the stock on track to overtake Amazon in value”
Listen at 1:14
Retail traders have been a key driver of SpaceX stock’s strong start.
“part of this is because of retail traders, which have been a key driver of the hot start”
Listen at 1:24
SpaceX stock options trading has already attracted record volume.
“options trading for the Rocket stock began today and has already drawn record volume”
Listen at 1:36
SpaceX has overtaken Amazon in market capitalization.
“it actually has overtaken Amazon's market cap”
Listen at 2:01
Netflix stock is down about 3.9%, reaching its lowest intraday level since February.
“Netflix. That's ticker NFL X currently slipping about 3.9% to hit its lowest intraday level since February.”
Listen at 2:21
FDA briefing documents appear favorable and may support approval of Moderna’s flu vaccine.
“the documents do read very favorably for the vaccine and potentially could mean that it could get approval”
Listen at 3:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Netflix
Food and Drug AdministrationListen to the full episode and explore every guest, topic, and moment on PodLume.